Adapt Pharma has announced that Mike Kelly has been appointed as President of U.S. Operations. In this role, Mike will have responsibility for all of the company's U.S. operating activities. He will report to Eunan Maguire, Chief Operating Officer of Adapt Pharma.
Mike brings nearly three decades of pharmaceutical experience, playing an instrumental role in the creation, development and strengthening of specialty brands and businesses for a number of pharmaceutical companies. He joins Adapt Pharma from Covis Pharmaceuticals, Inc., where he served as Chief Executive Officer and Board member. Prior to Covis, Mike was a member of the founding management team of Azur Pharma and later, following a strategic merger, served as Senior Vice President of Sales and Marketing for Jazz Pharmaceuticals PLC. Mike earned his Master of Business Administration from Rider University in Lawrenceville, New Jersey.
"I am delighted to welcome Mike to Adapt Pharma. Mike has established a highly successful track record in leadership roles in specialty pharmaceuticals," said Seamus Mulligan, Chairman and Chief Executive Officer of Adapt Pharma. "His experience will be of great value as Adapt Pharma expands its commercial presence, starting with the launch of NARCAN® (naloxone HCl) Nasal Spray."
"I am excited to take on this role and look forward to working with our talented senior leadership to grow Adapt Pharma in the U.S.," said Mike. "Most immediately, I am proud to support a product like NARCAN® Nasal Spray and expand the opportunity to help Americans, impacted by opioid overdose in our country."